Merck & Co., Inc. (MRK) Stock Analysis
A live, multi-source view of Merck & Co., Inc. (MRK): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
Sector: Healthcare · Industry: Drug Manufacturers - General · United States · 73,000 employees · merck.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Merck & Co., Inc. (MRK) had a market capitalization of $370.89B, a trailing P/E of 120.3 (forward 15.7), a dividend yield of 2.23% and a beta of 0.23; the shares traded in a 52-week range of $77.58 – $156.92 (78.8% over the year).
- Market cap
- $370.89B
- Enterprise value
- $417.71B
- Trailing P/E
- 120.3
- Forward P/E
- 15.7
- PEG ratio
- 2.92
- Price / book
- 8.85
- EPS (trailing)
- $1.25
- EPS (forward)
- $9.55
- Dividend yield
- 2.23%
- Payout ratio
- 268.8%
- Ex-dividend date
- 2026-09-15
- 52-week range
- $77.58 – $156.92
- 52-week change
- 78.8%
- Beta
- 0.23
- Average volume
- 10.5M
- Shares outstanding
- 2.47B
- Short % of float
- 0.99%
- Profit margin
- 4.8%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Merck & Co., Inc. (MRK) last closed at $144.71 (the last completed close before that scan).
Technicals at the scan: RSI 52 (neutral territory), price -1.8% versus its 20-day average, 20-day versus 50-day average spread +8.6%, MACD histogram -1.14.
Sentiment inputs: 64% of recent Finnhub-scored headlines read bullish; StockTwits 88% bullish; analyst consensus score 72/100.
Next scheduled company event: in 26 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 2 buys and 1 sell of MRK; corporate insiders filed 0 buys and 17 sells (7 distinct filers, latest disclosure 2026-09-09). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Richard R. Deluca (0B/8S), David R. Maraldo (0B/3S), David Michael Williams (0B/3S), Maria Elvira Salazar (2B/0S), Chirfi Guindo (0B/2S), Jennifer Zachary (0B/1S). Who is trading what
RapidTradeView pick record
MRK has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Merck & Co., Inc. (MRK) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MRK.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.